Overview

Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout

Status:
Unknown status
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether levotofisopam is safe and effective in the treatment of hyperuricemia and gout.
Phase:
Phase 2
Details
Lead Sponsor:
Pharmos
Treatments:
Tofisopam